Does the media favor CELC or BTSG?

In the previous week, Celcuity had 21 more articles in the media than BrightSpring Health Services. MarketBeat recorded 28 mentions for Celcuity and 7 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.96 beat Celcuity's score of 0.05 indicating that BrightSpring Health Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 7 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Neutral BrightSpring Health Services 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor FMS or CELC?

In the previous week, Celcuity had 25 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 28 mentions for Celcuity and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.05 beat Celcuity's score of 0.05 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 7 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Neutral

Does the media refer more to HIMS or CELC?

In the previous week, Celcuity had 21 more articles in the media than Hims & Hers Health. MarketBeat recorded 28 mentions for Celcuity and 7 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.68 beat Celcuity's score of 0.05 indicating that Hims & Hers Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 7 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Neutral

Which has better valuation & earnings, CELC or PACS?

PACS Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Celcuity N/A N/A -$177.04M -$3.90 N/A PACS Group $5.29B 1.36 $191.54M $1.56 29.15

Is CELC or PACS more profitable?

PACS Group has a net margin of 4.49% compared to Celcuity's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Celcuity N/A -244.61% -50.22% PACS Group 4.49% 26.47% 4.36%

Does the media prefer CELC or PACS?

In the previous week, Celcuity had 26 more articles in the media than PACS Group. MarketBeat recorded 28 mentions for Celcuity and 2 mentions for PACS Group. PACS Group's average media sentiment score of 0.39 beat Celcuity's score of 0.05 indicating that PACS Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 7 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Neutral PACS Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings and valuation, BLLN or CELC?

Billiontoone has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Billiontoone $354.54M 17.04 $7.45M $0.55 238.80 Celcuity N/A N/A -$177.04M -$3.90 N/A

Is BLLN or CELC more profitable?

Billiontoone's return on equity of 0.00% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Billiontoone N/A N/A N/A Celcuity N/A -244.61% -50.22%

Does the media prefer BLLN or CELC?

In the previous week, Celcuity had 25 more articles in the media than Billiontoone. MarketBeat recorded 28 mentions for Celcuity and 3 mentions for Billiontoone. Billiontoone's average media sentiment score of 0.57 beat Celcuity's score of 0.05 indicating that Billiontoone is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 7 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Neutral

Celcuity (CELC) Competitors

$89.95 +1.96 (+2.23%)

As of 11:42 AM Eastern

Compare

CELC vs. BTSG, FMS, HIMS, PACS, and BLLN

Should you buy Celcuity stock or one of its competitors? MarketBeat compares Celcuity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Celcuity include BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), PACS Group (PACS), and Billiontoone (BLLN). These companies are all part of the "healthcare" industry.

How does Celcuity compare to BrightSpring Health Services?

Celcuity (NASDAQ:CELC) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.

In the previous week, Celcuity had 21 more articles in the media than BrightSpring Health Services. MarketBeat recorded 28 mentions for Celcuity and 7 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.96 beat Celcuity's score of 0.05 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	7 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	3 Negative mention(s)	2 Very Negative mention(s)	Neutral
BrightSpring Health Services	5 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

BrightSpring Health Services has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
BrightSpring Health Services	$12.91B	1.10	$190.67M	$1.41	50.87

Celcuity presently has a consensus target price of $155.18, suggesting a potential upside of 72.84%. BrightSpring Health Services has a consensus target price of $70.12, suggesting a potential downside of 2.25%. Given Celcuity's higher possible upside, research analysts clearly believe Celcuity is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
BrightSpring Health Services	0 Sell rating(s)	1 Hold rating(s)	18 Buy rating(s)	1 Strong Buy rating(s)	3.00

BrightSpring Health Services has a net margin of 2.27% compared to Celcuity's net margin of 0.00%. BrightSpring Health Services' return on equity of 14.63% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
BrightSpring Health Services	2.27%	14.63%	4.41%

63.3% of Celcuity shares are held by institutional investors. 13.3% of Celcuity shares are held by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Celcuity has a beta of 0.16, meaning that its stock price is 84% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.79, meaning that its stock price is 79% more volatile than the broader market.

Summary

BrightSpring Health Services beats Celcuity on 12 of the 16 factors compared between the two stocks.

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, media sentiment and dividends.

In the previous week, Celcuity had 25 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 28 mentions for Celcuity and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.05 beat Celcuity's score of 0.05 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	7 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	3 Negative mention(s)	2 Very Negative mention(s)	Neutral

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 13.3% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market. Comparatively, Celcuity has a beta of 0.16, suggesting that its stock price is 84% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Celcuity's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%
Celcuity	N/A	-244.61%	-50.22%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$19.36B	0.69	$1.11B	$1.90	13.00
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $28.00, indicating a potential upside of 13.38%. Celcuity has a consensus price target of $155.18, indicating a potential upside of 72.84%. Given Celcuity's stronger consensus rating and higher probable upside, analysts plainly believe Celcuity is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

Summary

Fresenius Medical Care AG & Co. KGaA beats Celcuity on 9 of the 15 factors compared between the two stocks.

How does Celcuity compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Celcuity (NASDAQ:CELC) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Comparatively, 13.3% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Hims & Hers Health has a beta of 2.35, indicating that its share price is 135% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.16, indicating that its share price is 84% less volatile than the broader market.

Celcuity has a net margin of 0.00% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Celcuity	N/A	-244.61%	-50.22%

Hims & Hers Health has higher revenue and earnings than Celcuity. Hims & Hers Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.30	$128.37M	-$0.09	N/A
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

Hims & Hers Health presently has a consensus target price of $30.70, indicating a potential downside of 8.15%. Celcuity has a consensus target price of $155.18, indicating a potential upside of 72.84%. Given Celcuity's stronger consensus rating and higher possible upside, analysts clearly believe Celcuity is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

In the previous week, Celcuity had 21 more articles in the media than Hims & Hers Health. MarketBeat recorded 28 mentions for Celcuity and 7 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.68 beat Celcuity's score of 0.05 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	7 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	3 Negative mention(s)	2 Very Negative mention(s)	Neutral

Summary

Hims & Hers Health beats Celcuity on 8 of the 15 factors compared between the two stocks.

How does Celcuity compare to PACS Group?

Celcuity (NASDAQ:CELC) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

Celcuity currently has a consensus target price of $155.18, suggesting a potential upside of 72.84%. PACS Group has a consensus target price of $50.60, suggesting a potential upside of 11.27%. Given Celcuity's stronger consensus rating and higher probable upside, research analysts plainly believe Celcuity is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

PACS Group has a net margin of 4.49% compared to Celcuity's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
PACS Group	4.49%	26.47%	4.36%

In the previous week, Celcuity had 26 more articles in the media than PACS Group. MarketBeat recorded 28 mentions for Celcuity and 2 mentions for PACS Group. PACS Group's average media sentiment score of 0.39 beat Celcuity's score of 0.05 indicating that PACS Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	7 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	3 Negative mention(s)	2 Very Negative mention(s)	Neutral
PACS Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PACS Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
PACS Group	$5.29B	1.36	$191.54M	$1.56	29.15

63.3% of Celcuity shares are owned by institutional investors. 13.3% of Celcuity shares are owned by company insiders. Comparatively, 70.1% of PACS Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Celcuity has a beta of 0.16, suggesting that its stock price is 84% less volatile than the broader market. Comparatively, PACS Group has a beta of -0.08, suggesting that its stock price is 108% less volatile than the broader market.

Summary

PACS Group beats Celcuity on 9 of the 15 factors compared between the two stocks.

How does Celcuity compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Celcuity (NASDAQ:CELC) are both mid-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

Billiontoone's return on equity of 0.00% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Celcuity	N/A	-244.61%	-50.22%

63.3% of Celcuity shares are held by institutional investors. 50.2% of Billiontoone shares are held by insiders. Comparatively, 13.3% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Billiontoone currently has a consensus target price of $126.00, suggesting a potential downside of 4.07%. Celcuity has a consensus target price of $155.18, suggesting a potential upside of 72.84%. Given Celcuity's stronger consensus rating and higher probable upside, analysts plainly believe Celcuity is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

Billiontoone has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$354.54M	17.04	$7.45M	$0.55	238.80
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

In the previous week, Celcuity had 25 more articles in the media than Billiontoone. MarketBeat recorded 28 mentions for Celcuity and 3 mentions for Billiontoone. Billiontoone's average media sentiment score of 0.57 beat Celcuity's score of 0.05 indicating that Billiontoone is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	7 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	3 Negative mention(s)	2 Very Negative mention(s)	Neutral

Summary

Billiontoone beats Celcuity on 8 of the 13 factors compared between the two stocks.

Get Celcuity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CELC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CELC vs. The Competition

Export

Metric	Celcuity	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$4.38B	$3.64B	$6.80B	$12.40B
Dividend Yield	N/A	2.16%	2.67%	9.39%
P/E Ratio	-23.02	20.61	27.08	24.12
Price / Sales	N/A	304.69	516.47	92.58
Price / Cash	N/A	60.31	26.68	47.25
Price / Book	41.38	8.04	10.63	6.23
Net Income	-$177.04M	$23.81M	$3.60B	$331.53M
7 Day Performance	-19.15%	-1.31%	-1.08%	-1.30%
1 Month Performance	2.31%	2.48%	1.28%	-1.40%
1 Year Performance	563.11%	44.40%	24.71%	18.15%

Celcuity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CELC Celcuity	3.3843 of 5 stars	$89.95 +2.2%	$155.18 +72.5%	+547.5%	$4.39B	N/A	N/A	40
BTSG BrightSpring Health Services	3.491 of 5 stars	$70.12 +0.7%	$70.12 0.0%	+253.6%	$13.81B	$12.91B	49.65	23,500
FMS Fresenius Medical Care AG & Co. KGaA	4.2417 of 5 stars	$24.20 -1.0%	$28.00 +15.7%	-9.3%	$13.01B	$22.20B	12.75	1,488	Positive News
HIMS Hims & Hers Health	2.6794 of 5 stars	$34.87 +1.4%	$30.70 -12.0%	-35.1%	$8.08B	$2.35B	N/A	2,442
PACS PACS Group	2.8262 of 5 stars	$43.89 +1.4%	$50.60 +15.3%	+273.7%	$6.95B	$5.29B	28.15	47,455

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CELC) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Celcuity (CELC) Competitors

CELC vs. BTSG, FMS, HIMS, PACS, and BLLN

How does Celcuity compare to BrightSpring Health Services?

Summary

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Celcuity compare to Hims & Hers Health?

Summary

How does Celcuity compare to PACS Group?

Summary

How does Celcuity compare to Billiontoone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CELC vs. The Competition

Celcuity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Celcuity (CELC) Competitors

CELC vs. BTSG, FMS, HIMS, PACS, and BLLN

How does Celcuity compare to BrightSpring Health Services?

Does the media favor CELC or BTSG?

Which has higher valuation & earnings, CELC or BTSG?

Do analysts recommend CELC or BTSG?

Is CELC or BTSG more profitable?

Do insiders and institutionals have more ownership in CELC or BTSG?

Which has more volatility and risk, CELC or BTSG?

Summary

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Does the media favor FMS or CELC?

Do institutionals and insiders have more ownership in FMS or CELC?

Which has more risk & volatility, FMS or CELC?

Is FMS or CELC more profitable?

Which has better valuation & earnings, FMS or CELC?

Do analysts prefer FMS or CELC?

Summary

How does Celcuity compare to Hims & Hers Health?

Do institutionals and insiders have more ownership in HIMS or CELC?

Which has more volatility & risk, HIMS or CELC?

Is HIMS or CELC more profitable?

Which has higher valuation & earnings, HIMS or CELC?

Do analysts prefer HIMS or CELC?

Does the media refer more to HIMS or CELC?

Summary

How does Celcuity compare to PACS Group?

Do analysts recommend CELC or PACS?

Is CELC or PACS more profitable?

Does the media prefer CELC or PACS?

Which has better valuation & earnings, CELC or PACS?

Do insiders & institutionals hold more shares of CELC or PACS?

Which has more volatility & risk, CELC or PACS?

Summary

How does Celcuity compare to Billiontoone?

Is BLLN or CELC more profitable?

Do institutionals & insiders believe in BLLN or CELC?

Do analysts rate BLLN or CELC?

Which has better earnings and valuation, BLLN or CELC?

Does the media prefer BLLN or CELC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CELC vs. The Competition

Celcuity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools